The properties of ornithine decarboxylase (OrnDCase) from mouse epidermis and benign epidermal tumors (papillomas) induced by the initiation-promotion protocol were compared. When crude extracts from each tissue were incubated at 55TC, epidermal OrnDCase was rapidly inactivated, but the papilloma OrnDCase was more heat stable. Each offive individual papilloma extracts contained OrnDCase activity that was considerably more resistant to heat inactivation than was epidermal OrnDCase. Mixing of a papilloma and epidermal extract produced an intermediate heat-inactivation profile, suggesting that the differences in OrnDCase heat stability are not due to non-OrnDCase components of the extracts. Kinetic analyses indicated that the papilloma OrnDCase has an altered affinity for its substrate, L-ornithine, OrnDCases, but not epidermal OrnDCase, were activated by GTP and to a lesser extent by CTP. Immunoblot analysis showed the existence of multiple forms of OrnDCase in both epidermis and papilloma that differed in isoelectric point but not subunit molecular weight. None of the species of OrnDCase present in the epidermal extract coincided with the species present in papilloma. These results suggest that one consequence of neoplastic transformation in this in vivo system is the presence of an OrnDCase protein in benign tumors that differs structurally and functionally from the OrnDCase present in normal epidermis. The possible mechanisms responsible for these results and their significance for neoplastic development in this tissue are discussed.
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Epidermal tumors can be efficiently induced in mice by a single application of a carcinogen followed by frequent applications of an effective tumor promoter, such as the phorbol ester phorbol 12-myristate 13-acetate (PMA) . This initiation-promotion protocol results in high yields of benign tumors (papillomas) only a few of which progress to malignant carcinomas. Despite a great deal of investigation over the last 50 years, very little is known with certainty at the cellular or molecular level of the mechanisms responsible for multistage carcinogenesis in this epithelium. What is known, in both mouse skin and many experimental systems in cell culture, is that active phorbol esters can affect the expression of specific genes and whole differentiation programs (1, 2) . It seems likely that an important feature of tumor promotion is the ability of promoters to cause altered patterns of gene expression in at least some cells in the target tissue.
One of the genes whose expression has been shown to be influenced by PMA in mouse skin and many other cell types is ornithine decarboxylase (OrnDCase) (3) (4) (5) (6) . PMA treatment of mouse epidermis results in a rapid yet transient induction of OrnDCase activity of >200-fold (3) . Because the induction of OrnDCase in epidermis is heterogeneous at the cellular level, the extent ofinduction is probably even greater in focal areas of the epidermis after several PMA applications, as judged by immuno-localization studies using an anti-OrnDCase antibody (7) . The elevated levels of OrnDCase activity and polyamines induced by phorbol esters in skin are probably essential for effective promotion in this tissue (8) ; one set of data supporting this idea is the inhibitory effect on tumor promotion of difluoromethylornithine (F2Me-Orn), a very specific irreversible inhibitor of OrnDCase (9, 10) . In skin tumors induced by an initiation-promotion protocol, the basal level of OrnDCase is much higher than in normal skin (11, 12) , perhaps due to the apparently much longer half-life for the tumor enzyme than the normal enzyme. Based on these results, we decided to ask whether there were any detectable differences in the properties of OrnDCase isolated from normal skin vs. skin tumors. Our preliminary results clearly indicate that this enzyme differs in its enzymatic properties and structure when isolated from these two sources. While the underlying mechanism(s) remain to be elucidated, our data suggest that during tumor induction in this system the cellular control of this important regulatory gene changes. It Enzyme Assays. OrnDCase activity was measured at 370C as described (6) . Results are expressed as units/mg ofprotein (1 unit = 1 nmol of CO2 produced in 30 min). For determination of Km and Vmax values, extracts were assayed at L-ornithine concentrations from 0.01 mM to 4 mM, and kinetic parameters were determined from Lineweaver-Burk reciprocal plots. For determination of heat sensitivity, extracts containing OrnDCase activity (at 0C) were placed in a 550C water bath, and aliquots were removed to chilled tubes at 00C. OrnDCase activity was then measured at 370C as described above.
To assess possible bacterial contamination, immediately after homogenization, aliquots of papilloma homogenates were streaked on 5% (vol/vol) sheep blood agar and MacConkey agar plates to grow up any bacteria present. Diagnostic tests indicated the major strains present were Staphylococcus epidermidis and Enterobacter aerogenes. These strains were then grown individually in liquid nutrient broth and pelleted, and extracts were prepared as described (13) . The extracts were then assayed for OrnDCase activity in the same way as mammalian extracts.
Immunoblotting Procedures. Two-dimensional gel electrophoresis was performed as described by O'Farrell (14) . Following isoelectric focusing in the first dimension (pH range 5-7), proteins were separated in 10% NaDodSO4/ PAGE in the second dimension. Following electrophoretic transfer of proteins to nitrocellulose, immunoblotting was carried out exactly as described by Persson et al. (15) . The antibody used was generously provided by Lo Persson and Anthony Pegg and used at a dilution of 1:20,000 (for papilloma extracts) or 1:5000 (for epidermal extracts). Detection of bound antibodies was accomplished with a Vectastain ABC kit, using a protocol from the supplier (Vector Laboratories, Burlingame, CA).
RESULTS
Our initial approach to the question of possible differences in epidermal vs. skin tumor OrnDCase activity was to determine the sensitivity to heat inactivation of the enzyme isolated from PMA-induced normal epidermis and from individual benign tumors (papillomas) induced by the twostage protocol. In these and all subsequent studies tumors were excised from animals that had not been treated with PMA for at least 1 week to minimize the possible residual effect of the last application of PMA on OrnDCase activity. The PMA-induced OrnDCase from normal epidermis was then compared to the constitutively expressed high level of OrnDCase present in epidermal tumors (11, 12) . As shown in Fig. 1 , OrnDCase isolated from epidermis was quite heat sensitive, as contrasted to the greater stability to heat inactivation of OrnDCase isolated from each of five papilloma extracts. In most cases, a considerable portion of the total OrnDCase activity present in the papilloma extracts was quite stable even after 8 min at 55°C. For example, 65%, 60%, and 25% of initial OrnDCase activity in papillomas A, B, and D, respectively, remained after 8 min at 55°C while less than 5% of epidermal OrnDCase remained after only 2 min of (11, 12) , but were not consistently higher (or lower) than that of PMA-induced normal epidermis (Table 1) .
A third line of investigation concerned the effect of nucleotides on epidermal vs. papilloma OrnDCase activity. As reported for other mammalian OrnDCases (16, 17) , the enzyme from epidermis was unaffected by the presence of ATP, CTP, or GTP in the assay mixture (Table 2) . However, the papilloma enzyme was stimulated more than 2-fold by GTP and slightly by CTP ( Table 2) . The stimulation by GTP of OrnDCase activity has been observed in all papilloma extracts tested (n = 4) but was never observed in epidermal extracts. The Kl,2 for GTP activation of papilloma OrnDCase was approximately 0.2 AM (data not shown).
Although not considered likely, the possibility existed that the above differences in heat sensitivity, ornithine affinity, and activation by nucleotides between epidermal vs. papilloma OrnDCase were due to the presence of a massive The Km values for L-ornithine for both enzymes were greater than 2.5 mM while their heat sensitivities resembled the mouse epidermal OrnDCage (data not shown). Thus, if bacterial OrnDCase is a contaminant of the papilloma extracts, it is at best a very minor one.
The preceding differences in the properties of epidermal vs. papilloma OrnDCase suggest that the two enzymes may be structurally different. To address this question directly, crude extracts from both sources were analyzed by twodimensional immunoblotting procedures. The antibody used in this procedure was a rabbit polyclonal antiserum raised against mouse kidney OrnDCase, which we have shown recognizes both mouse epidermal and papilloma OrnDCase in tissue sections (7) . As shown in Fig. 3 , both epidermal and papilloma extracts contain multiple forms of OrnDCase, yet the enzyme isolated from papilloma is clearly different from the epidermal enzyme. The papilloma extract contained at least four major forms of OrnDCase differing in isoelectric point values (pl, 5.2-5.5) but not in molecular weight. Similarly, the epidermal extract contained multiple pI forms (pI, 6.2-6.5). Each of three additional papilloma extracts examined gave multiple pl forms (pI, 5.3-5.7) of OrnDCase while the pl forms present in mouse epidermis were reproducibly in the range of 6-6.6 (T.G.O., T.M., and M.H., data not shown). The molecular weight of OrnDCase in the two extracts did not appear to be significantly different.
DISCUSSION
In this report, we document that the OrnDCase activity present in mouse skin papillomas induced by the initiation-promotion protocol has different properties than the PMA-induced enzyme isolated from the corresponding normal tissue, mouse epidermis. The evidence for this statement is based on four independent sets of data: (i) Heat stability: In all papilloma extracts tested, OrnDCase activity was substantially more resistant to heat inactivation at 550C, in some cases remarkably so. (it) Kinetic data: All papilloma OrnDCases tested exhibited a higher apparent Km for Lornithine than the epidermal enzyme. (iii) Activation by GTP: This nucleotide at least doubled the OrnDCase activity of papilloma extracts but was without effect on the epidermal enzyme. (iv) Two-dimensional gel electrophoretic analysis of immunoreactive OrnDCase: Immunoblotting of crude extracts revealed multiple pI forms of both epidermal and papilloma OrnDCase, yet these different molecular forms did not coincide. While the subunit molecular weights were similar, the epidermal enzyme(s) migrated to a more basic region of the isoelectric focusing gel than did the papilloma enzyme(s).
There appears to be no simple relationship between the kinetic properties of the individual papilloma OrnDCases and their heat sensitivities. While the apparent Km values for L-ornithine appear to cluster around two values, 0.3 mM and 1.0 mM, and some extracts are markedly more heat stable than others (Fig. 1) , the two properties are not directly related. Thus, OrnDCase from papilloma A has an apparent Km for L-ornithine of 1.1 mM and is quite heat stable while the enzyme from papilloma B is also heat stable, but has a Km for L-ornithine of 0.28 mM. Regardless of heat stability or L-ornithine affinity, all papilloma enzymes tested are activated by GTP (Table 2 and unpublished data). Given the existence of multiple forms of OrnDCase in both extracts (Fig. 3) The existence of multiple biochemical forms of OrnDCase has also been demonstrated in testosterone-induced mouse kidney (21, 22) . In this tissue, two forms of identical subunit molecular weight but different pI values have been detected (21) , while another study has reported evidence for two species of OrnDCase in this tissue with differing heat sensitivities (22) . A cell line established from a human neuroblastoma exhibits two nonidentical subunits of Mr 55,000 and 60,000 that can be labeled with 3H-labeled F2MeOrn (23) , which contrasts with the presence of a single monomer of OrnDCase in rodent cells (24) . Interestingly the neuroblastoma enzyme had a very long half-life in vivo (8 hr) and was quite resistant to inhibition by F2MeOrn compared to mouse kidney, despite the fact that it was not subjected to F2MeOrn treatment either in culture or in the patient from which the tumor was removed (23) . However, the properties of OrnDCase from the normal tissue of origin of this tumor were not described. When normal rat liver OrnDCase was compared to rat hepatoma OrnDCase, no structural differences were found, even though differences between the mouse kidney enzyme and the rat enzyme could be readily detected (24 normal skin (3), yet both benign (papillomas) and malignant (carcinomas) tumors produced by promoter treatment of carcinogen-initiated skin exhibit constitutively high levels of OrnDCase activity long after the last promoter treatment (11, 12) . Suggestive evidence has been published that the in vivo half-life of OrnDCase is prolonged in papillomas (8, 12) compared to the rapid turnover of the enzyme in PMAinduced epidermis (3). Thus, the available evidence suggests that the altered structure of OrnDCase in papillomas reflected in its greater heat stability and altered kinetic properties may confer a greater resistance to in vivo degradation and account for the higher basal level of OrnDCase in papillomas measured biochemically (12) or immunologically (7) . Whatever the mechanism responsible, the existence of a biochemically different OrnDCase in every epidermal papilloma examined (n > 10) suggests that this phenotypic change may be important in the evolution of this altered cell population. In view of the importance of sufficient levels of polyamines for cell proliferation, a genetic or epigenetic change leading to constitutively high levels of OrnDCase activity may ensure more than adequate intracellular levels of polyamines in at least some cells in the epidermis undergoing two-stage carcinogenesis and confer on cells so endowed a selective growth advantage and/or loss of terminal differentiation potential. Thus, the altered expression of OrnDCase, presumably in combination with other changes in gene expression [including oncogene expression (25) ], may be at least partly responsible for the early stages of neoplastic development in this tissue and not simply incidental to it.
